International Flavors & Fragrances Inc. (IFF)
Market Cap | 20.23B |
Revenue (ttm) | 11.48B |
Net Income (ttm) | 243.00M |
Shares Out | 255.74M |
EPS (ttm) | 0.95 |
PE Ratio | 83.32 |
Forward PE | 18.80 |
Dividend | $1.60 (2.02%) |
Ex-Dividend Date | Jun 20, 2025 |
Volume | 1,143,840 |
Open | 79.16 |
Previous Close | 79.06 |
Day's Range | 78.76 - 79.50 |
52-Week Range | 65.85 - 106.77 |
Beta | 1.23 |
Analysts | Buy |
Price Target | 94.82 (+19.89%) |
Earnings Date | May 6, 2025 |
About IFF
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, pharma solutions, and complementary adjacent products in the United States, Europe, and internationally. It operates in four segments Nourish, Health & Biosciences, Scent, and Pharma Solutions. The Nourish segment consists of portfolio of natural-based ingredients that includes plant-based specialty food ingredients, such as soy and pea protein with value-added formulations, emulsifiers, and sweeteners... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 12 analysts, the average rating for IFF stock is "Buy." The 12-month stock price forecast is $94.82, which is an increase of 19.89% from the latest price.
News

Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions
Roquette Announces a New Organization following the Acquisition of IFF Pharma Solutions The company launches two renewed and strengthened Business Groups, and appoints their new leaders Lille, May 5, ...

IFF Announces Tender Offers for Certain Outstanding Series of Notes
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced today the commencement of tender offers to purchase for cash certain of its outstanding series of notes listed in the tables below (collectively, t...

IFF Declares Dividend for Second Quarter 2025
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 11, 202...

IFF Completes Divestiture of Pharma Solutions Business Unit
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that it has successfully completed the previously announced divestiture of its Pharma Solutions business unit to Roquette. “The completion of...

IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, will showcase its sustainable solutions at Excipient World 2025. The team will feature sustainable ...

IFF Expands Pet Portfolio with Latest Science-driven Solutions
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF), a global powerhouse in bioscience and innovation, today announced a groundbreaking expansion of its pet portfolio. This launch marks a significant leap in I...

IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods™ Europe 2025
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event. The team will showcase its cutti...

IFF Opens Dubai Creative Center With Perfumery Art Studio
DUBAI, United Arab Emirates--(BUSINESS WIRE)--IFF (NYSE: IFF) announced the inauguration of its Scent Dubai Creative Center, a 2,000-square-meter addition to the company's facility in the Dubai Scienc...

IFF to Release First Quarter 2025 Results on May 6, 2025
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE:IFF) today announced that it will release its first quarter 2025 earnings results following the market close on Tuesday, May 6, 2025. The management team ...

IFF Opens Mexico Business Hub at Tecnoparque
NEW YORK--(BUSINESS WIRE)--To further strengthen its ability to serve customers with leading innovations, IFF (NYSE: IFF) announced it will combine the majority of its business operations in Mexico at...

IFF Unveils Cutting-Edge Citrus Innovation Center in Florida
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced the opening of the Citrus Innovation Center in Lakeland, Florida, in partnership with Florida Polytechnic University. This 30,000 square foot...

IFF Pharma Solutions Launches Low Nitrite METHOCEL™ HPMC for Nitrosamine Mitigation
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global leader in polymer innovations, today announced the launch of Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC), a range o...

IFF Introduces Science of Performance: A New Approach to Elevating Scent Design
PARIS--(BUSINESS WIRE)--IFF (NYSE: IFF) unveils its Science of Performance program, a comprehensive, science-driven suite that enhances fragrance creation by increasing efficiency and precision to man...

IFF and Kemira Form Joint Venture To Produce Sustainable Biobased Materials at Scale
NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of a...

IFF Pharma Solutions Brings Next-Gen Excipient Innovations to CPHI Japan 2025
TOKYO--(BUSINESS WIRE)--IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge excipient technologies at CPHI Japan 2025. The IFF Pharma Solutions team will highlight its innovations in oral d...

IFF Declares Dividend for First Quarter 2025
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 11, 20...

IFF Announces Expansion of Cedar Rapids, Iowa Ingredients Facility
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today unveiled plans to expand its Cedar Rapids, Iowa facility to capture a larger share of the booming healthy snacks market both in the U.S. and globally. ...

IFF Announces Executive Leadership Team Aligned With New Operating Model
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company's external reporting structure. After 21 years of dedicated service to IFF, Simo...

International Flavors & Fragrances Inc. (IFF) Q4 2024 Earnings Call Transcript
International Flavors & Fragrances Inc. (NYSE:IFF) Q4 2024 Earnings Call Transcript February 19, 2025 9:00 AM ET Company Participants Michael Bender - Director, Investor Relations Erik Fyrwald - Chie...

IFF Reports Fourth Quarter and Full Year 2024 Results
NEW YORK--(BUSINESS WIRE)---- $IFF--International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the fourth quarter and full year ended December 31, 2024. Full year 2024 Consolid...

IFF to Release Fourth Quarter & Full Year 2024 Results on Feb. 18, 2025; IFF to Present at 2025 CAGNY Conference on Feb. 20, 2025
NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE:IFF) today announced that it will release its fourth quarter and full year 2024 earnings results following the market close on Tuesday, Feb. 18, 2025. The...

IFF Announces Board of Directors Changes
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today unveiled the next phase in the evolution of its Board of Directors, aimed at bolstering the company's long-term strategic vision and driving profitable...

IFF Names Michael DeVeau Chief Financial Officer
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that Michael DeVeau—currently Senior Vice President, Corporate Finance and Investor Relations at IFF—has been named the company's Executive V...

Roquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma Solutions
Roquette Successfully Completes Inaugural EUR 1.2 billion Bond Offering to Support its Transformative Acquisition of IFF Pharma Solutions

Fragrance Maker IFF Positioned For Growth With Revitalized R&D And Attractive Valuation: Analyst
BofA Securities analyst Salvator Tiano upgraded International Flavors & Fragrances, Inc. IFF to Buy from Neutral, lowering the price forecast to $107 from $109.